Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Current Medicinal Chemistry|May 29, 2001
Hepatitis C virus protease inhibitors: current progress and future challengesC Steinkühler, U Koch, F Narjes, et al.Biochemistry|February 26, 2000
Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 proteaseF Narjes, M Brunetti, S Colarusso, et al.Journal of Medicinal Chemistry|June 1, 1990
Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazolesV G Matassa, T P Maduskuie, H S Shapiro, et al.The Journal of Biological Chemistry|March 4, 2000
Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexesS Di Marco, M Rizzi, C Volpari, et al.The Journal of Biological Chemistry|May 16, 2000
Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transferD Fattori, A Urbani, M Brunetti, et al.The EMBO Journal|March 16, 2000
Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domainG Barbato, D O Cicero, F Cordier, et al.British Journal of Pharmacology|November 1, 1993
L-694,247: a potent 5-HT1D receptor agonistM S Beer, J A Stanton, Y Bevan, et al.The American Review of Respiratory Disease|April 1, 1990
The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonistR D Krell, D Aharony, C K Buckner, et al.Journal of Medicinal Chemistry|May 28, 1993
Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptorsL J Street, R Baker, J L Castro, et al.Journal of Medicinal Chemistry|September 1, 1990
Synthesis and in vitro LTD4 antagonist activity of bicyclic and monocyclic cyclopentylurethane and cyclopentylacetamide N-arylsulfonyl amidesV G Matassa, F J Brown, P R Bernstein, et al.Pageof 2